韓国、仁川–(BUSINESS WIRE)–（ビジネスワイヤ） — （ビジネスワイヤ） — セルトリオンは、欧州委員会（EC）から2つのバイオシミラーにおいて3つの製品の販売承認を取得したと発表しました。承認を受けたEydenzelt® （CT-P42、アフリベルセプト）は、Eylea®のバイオシミラーであり、新生血管（滲出型）加齢黄斑変性（AMD）、網膜静脈閉塞症（RVO：分枝RVOまたは中心RVO）に伴う黄斑浮腫、糖尿病黄斑浮腫（DME）、および近視性脈絡膜新生血管（myopic CNV…
Category: Business
Mit der Zulassung von zwei weiteren Biosimilars erweitert Celltrion sein Biosimilar-Portfolio in der EU
INCHEON, Südkorea–(BUSINESS WIRE)–Wie Celltrion heute mitteilte, hat die Europäische Kommission die Marktzulassung für zwei Biosimilars erteilt:: Eydenzelt® (CT-P42, Aflibercept), ein Biosimilar zu Eylea®, zur Behandlung verschiedener Netzhauterkrank…
Celltrion breidt haar portfolio biosimilaire geneesmiddelen in de Europese Unie uit na goedkeuring van de Europese Commissie van twee biosimilars
INCHEON, Zuid-Korea–(BUSINESS WIRE)–Celltrion maakte vandaag bekend dat de Europese Commissie (EC) een vergunning heeft verleend voor het in de handel brengen van drie producten in twee biosimilars: Eydenzelt® (CT-P42, aflibercept), een biosimilar di…
Celltrion élargit son portefeuille de produits biosimilaires dans l’Union européenne suite à l’autorisation de deux nouvelles molécules biosimilaires par la Commission européenne
INCHEON, Corée du Sud–(BUSINESS WIRE)–Celltrion a annoncé aujourd’hui que la Commission européenne (CE) a accordé une autorisation de mise sur le marché pour trois produits dont deux molécules biosimilaires : Eydenzelt® (CT-P42, aflibercept), un médi…
Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars
INCHEON, South Korea–(BUSINESS WIRE)–Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® (CT-P42, aflibercept), a biosimilar to Eylea® to treat multiple…
National Vision’s 20/20 Quest Foundation Grants $25,000 to Optometry Giving Sight to Support Global Vision Care Initiatives
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc. announced today that its charitable foundation, 20/20 Quest, has awarded a $25,000 grant to Optometry Giving Sight (OGS). The funding supports OGS’s ongoing mission to combat preventable blindness and…
GeminiBio Appoints Mike Stella to Board
WEST SACRAMENTO, Calif.–(BUSINESS WIRE)–Gemini Bioproducts, LLC (“GeminiBio”), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Fort Lauderdale-based healthcare pr…
Luxa Biotechnology Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to RPESC-RPE-4W Transplantation for the Treatment of Dry Age-Related Macular Degeneration
FORT LEE, N.J.–(BUSINESS WIRE)–Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related macular degeneration (AMD), today announced that th…
Perfect Moment Expands Accessories Line with Puffer Tote Bags and Sunglasses
LONDON–(BUSINESS WIRE)–Perfect Moment Ltd. (NYSE American: PMNT), the high-performance, luxury skiwear and lifestyle brand that fuses technical excellence with fashion-led designs, has officially launched its new puffer tote bag and sunglass collecti…
“Father of Surgical Robotics” Dr. Fred Moll Joins ForSight Robotics Board of Directors
YOKNEAM ILLIT, Israel–(BUSINESS WIRE)– #Innovation–ForSight Robotics expands leadership team with Dr. Fred Moll, “father of surgical robotics,” joining Board of Directors; appoints VP R&D and VP People
$16.99 Bn Eylea Market Opportunities and Strategies to 2033: New Formulations to Enhance Treatments, Biosimilars Enhancing Accessibility, Awareness Campaigns Driving Expansion – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eylea Market Opportunities and Strategies to 2033” report has been added to ResearchAndMarkets.com’s offering. This report describes and explains the Eylea market and covers 2018-2023, termed the historic period, and 2023-…
Pantheon Vision Reflects on a Year of Milestones and Sets Bold Goals for 2025
BALTIMORE–(BUSINESS WIRE)–Pantheon Vision Reflects on a Year of Milestones and Sets Bold Goals for 2025
Dry Eye Disease Epidemiology Forecast Research 2020-2034: Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Disease – Epidemiology Forecast – 2034” report has been added to ResearchAndMarkets.com’s offering. The report delivers an in-depth understanding of Dry Eye Disease (DED), historical and forecasted epidemiology of …
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the fourth quarter and fiscal…
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the fourth quarter and fiscal…
Maui Jim Captures the Essence of Adventure and Connection in the New Vibrant Spring-Summer Advertising Campaign
PEORIA, Ill.–(BUSINESS WIRE)–Maui Jim, premium brand of polarized sunglasses now part of Kering Eyewear portfolio, unveils its new global advertising campaign, Color You Can Feel 2—a renewed invitation to experience the world with even more vivid and…
RadiusXR Announces Strategic Partnership with Thomas Osborne, MD, Chief Medical Officer at Microsoft Federal, and Clinical Professor at Stanford (adjunct)
SAN FRANCISCO–(BUSINESS WIRE)– #Ophthalmology–RadiusXR, a leader in transforming vision testing and eye care with advanced digital health platforms, is thrilled to announce an exciting addition to our team. Thomas Osborne, MD, Chief Medical Officer …
DigitalOptometrics to Preview World’s First Autonomous Slitlamp at Vision Expo East 2025
ORLANDO, Fla.–(BUSINESS WIRE)– #digitaloptometrics–DigitalOptometrics, a leader in remote eye care solutions, is proud to announce the launch of the world’s first and most advanced autonomous slitlamp with remote control capabilities at Vision Expo …
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the indep…
MediPrint Ophthalmics Advances Glaucoma Program, Expands Patent Portfolio, and Prepares for Key Industry Presentation
SAN DIEGO–(BUSINESS WIRE)–MediPrint® Ophthalmics, a clinical-stage ophthalmic drug delivery company, continues to advance its innovative glaucoma program following the successful completion of its Phase 2b clinical trial for LL-BMT1. As the company p…